NCT01543542View on ClinicalTrials.gov

A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Metastasis to Brain of Primary Cancer
Interventions
RADIATION

Whole Brain XRT 30Gy/10 fractions with

30 Gy of whole brain external beam radiation delivered in 10 fractions. Simultaneous in-field boost of brain lesions to 60 Gy.

Trial Locations (5)

T6G 1Z2

Alberta Health Services, Cross Cancer Institute, Edmonton

N6A 4L6

London Regional Cancer Program of the Lawson Health Research Institute, London

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

H2L 4M1

Centre Hospitalier De L'Universite de Montreal, Montreal

H3G 1A4

McGill University Health Centre, Montreal

Sponsors
All Listed Sponsors
collaborator

Ontario Institute for Cancer Research

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER